Management of tachyarrhythmias in children

Amy McCammond, Seshadri Balaji

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Management of tachycardia in children depends on the accurate characterization of the origin and mechanism of the rhythm, which can usually be achieved using noninvasive tests such as an electrocardiogram, Holter or cardiac event monitoring. Supraventricular tachycardia (SVT), the most common tachyarrhythmia in children, is most often due to an accessory pathway or dual AV nodal pathways. Adenosine and vagal maneuvers are useful to diagnose and terminate an acute event. Long-term management options include prophylactic drug therapy (aimed at suppressing the tachyarrhythmia) and catheter ablation. Ablation for SVT is highly successful with a low complication rate, and is first-line therapy in older patients. Ventricular arrhythmias are fortunately uncommon in children with normal hearts, and are seen primarily in the setting of abnormal myocardium and inherited ion channel defects. Management options for ventricular rhythms include drugs, catheter ablation and implantable cardioverterdefibrillators (ICDs). ICDs are indicated in patients with a risk of sudden death due to an arrhythmia.

Original languageEnglish (US)
Pages (from-to)490-502
Number of pages13
JournalCurrent Treatment Options in Cardiovascular Medicine
Volume14
Issue number5
DOIs
StatePublished - Oct 2012

Fingerprint

Tachycardia
Supraventricular Tachycardia
Catheter Ablation
Cardiac Arrhythmias
Sudden Death
Ion Channels
Adenosine
Myocardium
Electrocardiography
Drug Therapy
Pharmaceutical Preparations
Therapeutics

Keywords

  • Pediatric arrhythmia
  • Supraventricular tachycardia
  • Tachyarrhythmia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Management of tachyarrhythmias in children. / McCammond, Amy; Balaji, Seshadri.

In: Current Treatment Options in Cardiovascular Medicine, Vol. 14, No. 5, 10.2012, p. 490-502.

Research output: Contribution to journalArticle

@article{b541b0d982464aaebafe6d3d8d053797,
title = "Management of tachyarrhythmias in children",
abstract = "Management of tachycardia in children depends on the accurate characterization of the origin and mechanism of the rhythm, which can usually be achieved using noninvasive tests such as an electrocardiogram, Holter or cardiac event monitoring. Supraventricular tachycardia (SVT), the most common tachyarrhythmia in children, is most often due to an accessory pathway or dual AV nodal pathways. Adenosine and vagal maneuvers are useful to diagnose and terminate an acute event. Long-term management options include prophylactic drug therapy (aimed at suppressing the tachyarrhythmia) and catheter ablation. Ablation for SVT is highly successful with a low complication rate, and is first-line therapy in older patients. Ventricular arrhythmias are fortunately uncommon in children with normal hearts, and are seen primarily in the setting of abnormal myocardium and inherited ion channel defects. Management options for ventricular rhythms include drugs, catheter ablation and implantable cardioverterdefibrillators (ICDs). ICDs are indicated in patients with a risk of sudden death due to an arrhythmia.",
keywords = "Pediatric arrhythmia, Supraventricular tachycardia, Tachyarrhythmia",
author = "Amy McCammond and Seshadri Balaji",
year = "2012",
month = "10",
doi = "10.1007/s11936-012-0199-0",
language = "English (US)",
volume = "14",
pages = "490--502",
journal = "Current Treatment Options in Cardiovascular Medicine",
issn = "1092-8464",
publisher = "Current Science, Inc.",
number = "5",

}

TY - JOUR

T1 - Management of tachyarrhythmias in children

AU - McCammond, Amy

AU - Balaji, Seshadri

PY - 2012/10

Y1 - 2012/10

N2 - Management of tachycardia in children depends on the accurate characterization of the origin and mechanism of the rhythm, which can usually be achieved using noninvasive tests such as an electrocardiogram, Holter or cardiac event monitoring. Supraventricular tachycardia (SVT), the most common tachyarrhythmia in children, is most often due to an accessory pathway or dual AV nodal pathways. Adenosine and vagal maneuvers are useful to diagnose and terminate an acute event. Long-term management options include prophylactic drug therapy (aimed at suppressing the tachyarrhythmia) and catheter ablation. Ablation for SVT is highly successful with a low complication rate, and is first-line therapy in older patients. Ventricular arrhythmias are fortunately uncommon in children with normal hearts, and are seen primarily in the setting of abnormal myocardium and inherited ion channel defects. Management options for ventricular rhythms include drugs, catheter ablation and implantable cardioverterdefibrillators (ICDs). ICDs are indicated in patients with a risk of sudden death due to an arrhythmia.

AB - Management of tachycardia in children depends on the accurate characterization of the origin and mechanism of the rhythm, which can usually be achieved using noninvasive tests such as an electrocardiogram, Holter or cardiac event monitoring. Supraventricular tachycardia (SVT), the most common tachyarrhythmia in children, is most often due to an accessory pathway or dual AV nodal pathways. Adenosine and vagal maneuvers are useful to diagnose and terminate an acute event. Long-term management options include prophylactic drug therapy (aimed at suppressing the tachyarrhythmia) and catheter ablation. Ablation for SVT is highly successful with a low complication rate, and is first-line therapy in older patients. Ventricular arrhythmias are fortunately uncommon in children with normal hearts, and are seen primarily in the setting of abnormal myocardium and inherited ion channel defects. Management options for ventricular rhythms include drugs, catheter ablation and implantable cardioverterdefibrillators (ICDs). ICDs are indicated in patients with a risk of sudden death due to an arrhythmia.

KW - Pediatric arrhythmia

KW - Supraventricular tachycardia

KW - Tachyarrhythmia

UR - http://www.scopus.com/inward/record.url?scp=84870297864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870297864&partnerID=8YFLogxK

U2 - 10.1007/s11936-012-0199-0

DO - 10.1007/s11936-012-0199-0

M3 - Article

C2 - 22923097

AN - SCOPUS:84870297864

VL - 14

SP - 490

EP - 502

JO - Current Treatment Options in Cardiovascular Medicine

JF - Current Treatment Options in Cardiovascular Medicine

SN - 1092-8464

IS - 5

ER -